Group Created with Sketch.
< Back
2021 Track

Endocrine, Respiratory and Neuropharmacology Group

The development of novel drugs, treating pulmonary fibrosis.

These researchers are leading an asthma drug discovery venture aimed at treating symptoms of severe steroid-resistant asthma, with the potential use as a possible COVID-19 recovery drug.

Two approved drugs that are currently used to treat pulmonary fibrosis, help to slow but do not halt or cure the disease. There is a significant need for new drugs to treat the disease.

Researchers: Katie Leach, Karen Gregory and Jiayin Diao
(Monash Institute of Pharmaceutical Sciences)


More alumni

Curiosity got you?

Get in touch and find out which program is best for you

Want us to tell you about the cool stuff happening in the TRAM space?

Sign up for our newsletter to get key dates, reminders and advice delivered to your inbox.